Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim animal health nordics a/s - fipronilum,permethrinum - paikallisvaleluliuos - fiproniili, yhdistelmävalmisteet

Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim animal health nordics a/s - fipronilum,permethrinum - paikallisvaleluliuos - fiproniili, yhdistelmävalmisteet

Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim animal health nordics a/s - eprinomectin - kertavaleluliuos - 5 mg/ml - eprinomektiini

Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim animal health nordics a/s - dihydrostreptomycini sulfas - tabletti - 500 mg - dihydrostreptomysiini

Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim animal health nordics a/s - procaine benzylpenicillin - injektioneste, suspensio - 300 mg/ml - prokaiinipenisilliini

Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim animal health nordics a/s - borrelia afzelii,borrelia burgdorferi sensu stricto,borrelia garinii - injektioneste, suspensio

Europeiska unionen - finska - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. immuniteettia on osoitettu viikon kuluttua rhinotracheiitin, kalikiviruksen, chlamydophila felisin ja panleukopenia -komponenttien ensisijaisesta rokotuskurssista. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Europeiska unionen - finska - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Europeiska unionen - finska - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

Finland - finska - Fimea (Suomen lääkevirasto)

boehringer ingelheim vetmedica gmbh - pergolide mesilate - tabletti - 1 mg - pergolidi